Skip to main content

Table 3 Overall and subgroups meta-analysis of COX-2 rs689466 polymorphism and HNSCC risk

From: COX-2 rs689466, rs5275, and rs20417 polymorphisms and risk of head and neck squamous cell carcinoma: a meta-analysis of adjusted and unadjusted data

Overall and subgroups

No.

OR (95 % CI)

Heterogeneity (I2%/p)

A vs. G (unadjusted and adjusted)

 Overall (unadjusted)

5

1.08 (0.97–1.09)

7 %/0.37

 Overall (adjusted)

2

1.07 (0.84–1.36)

0 %/0.88

 Asians (unadjusted)

4

1.12 (1.00–1.25)

0 %/0.56

 Asians (adjusted)

2

1.07 (0.84–1.36)

0 %/0.88

 Caucasian (unadjusted)

1

0.92 (0.73–1.16)

NA

 OSCC (unadjusted)

3

1.01 (0.87–1.16)

80 %/0.008

 OSCC (adjusted)

1

1.03 (0.60–1.42)

NA

 LSCC (unadjusted)

1

0.96 (0.72–1.32)

NA

AA vs. GG (unadjusted)

 Overall

5

1.26 (1.01–1.57)

0 %/0.46

 Asians

4

1.25 (0.99–1.57)

14 %/0.32

 Caucasian

1

1.39 (0.70–2.73)

NA

 OSCC

3

1.07 (0.40–2.86)

86 %/<0.05

 LSCC

1

1.30 (0.69–2.45)

NA

AA vs. GA (unadjusted and adjusted)

 Overall (unadjusted)

5

1.21 (1.01–1.45)

28 %/0.23

 Overall (adjusted)

4

0.84 (0.69–1.03)

0 %/0.41

 Asians (unadjusted)

4

1.17 (0.97–1.42)

30 %/0.23

 Asians (adjusted)

3

0.89 (0.68–1.16)

23 %/0.27

 Caucasian (unadjusted)

1

1.78 (0.89–3.57)

NA

 Caucasian (adjusted)

1

0.79 (0.58–1.07)

NA

 OSCC (unadjusted)

3

0.88 (0.53–1.48)

76 %/0.01

 OSCC (adjusted)

2

1.23 (0.23–4.70)

67 %/0.08

 LSCC (unadjusted)

1

1.17 (0.71–1.93)

NA

 LSCC (adjusted)

1

1.16 (0.65–2.09)

NA

AA vs. GG + GA (unadjusted)

 Overall

5

1.20 (1.01–1.43)

12 %/0.34

 Asians

4

1.18 (0.99–1.41)

26 %/0.26

 Caucasian

1

1.52 (0.78–2.96)

NA

 OSCC

3

0.89 (0.50–1.58)

83 %/0.003

 LSCC

1

1.21 (0.75–1.94)

NA

AA + GA vs. GG (unadjusted and adjusted)

 Overall (unadjusted)

5

0.98 (0.84–1.15)

28 %/0.23

 Overall (adjusted)

2

0.93 (0.72–1.21)

0 %/0.84

 Asians (unadjusted)

4

1.07 (0.88–1.29)

13 %/0.33

 Asians (adjusted)

2

0.93 (0.72–1.21)

0 %/0.84

 Caucasian

1

0.83 (0.63–1.09)

NA

 OSCC (unadjusted)

3

1.03 (0.57–1.88)

75 %/0.02

 OSCC (adjusted)

1

0.78 (0.53–1.14)

NA

 LSCC (unadjusted)

1

1.17 (0.68–2.03)

NA

 LSCC (adjusted)

1

1.23 (0.71–2.15)

NA

  1. OSCC oral squamous cell carcinoma; HNSCC head and neck squamous cell carcinoma; LSCC laryngeal squamous cell carcinoma; OR odds ratio; CI confidence interval; NA not available